Formulation Development Outsourcing Market Size, Share & Trends

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Formulation Development Outsourcing Market Size Analysis

Global Formulation Development Outsourcing Market Introduction
By Service
1. Introduction
  1. Service By Value
2. Pre-Formulation Service
  1. By Value
3. Formulation Optimization
  1. By Value
By Dosage Form
1. Introduction
  1. Dosage Form By Value
2. Injectable
  1. By Value
3. Oral
  1. By Value
4. Topical
  1. By Value
5. Other Dosage Forms
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Oncology
  1. By Value
3. Genetic Disorders
  1. By Value
4. Neurology
  1. By Value
5. Infectious Diseases
  1. By Value
6. Respiratory
  1. By Value
7. Cardiovascular
  1. By Value
8. Other Applications
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical and Biopharmaceutical Companies
  1. By Value
3. Government and Academic Institutes
  1. By Value

North America Market Analysis

Introduction
By Service
1. Introduction
  1. Service By Value
2. Pre-Formulation Service
  1. By Value
3. Formulation Optimization
  1. By Value
By Dosage Form
1. Introduction
  1. Dosage Form By Value
2. Injectable
  1. By Value
3. Oral
  1. By Value
4. Topical
  1. By Value
5. Other Dosage Forms
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Oncology
  1. By Value
3. Genetic Disorders
  1. By Value
4. Neurology
  1. By Value
5. Infectious Diseases
  1. By Value
6. Respiratory
  1. By Value
7. Cardiovascular
  1. By Value
8. Other Applications
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical and Biopharmaceutical Companies
  1. By Value
3. Government and Academic Institutes
  1. By Value
U.S.
1. By Service
  1. Introduction
    1. Service By Value
  2. Pre-Formulation Service
    1. By Value
  3. Formulation Optimization
    1. By Value
2. By Dosage Form
  1. Introduction
    1. Dosage Form By Value
  2. Injectable
    1. By Value
  3. Oral
    1. By Value
  4. Topical
    1. By Value
  5. Other Dosage Forms
    1. By Value
3. By Applications
  1. Introduction
    1. Applications By Value
  2. Oncology
    1. By Value
  3. Genetic Disorders
    1. By Value
  4. Neurology
    1. By Value
  5. Infectious Diseases
    1. By Value
  6. Respiratory
    1. By Value
  7. Cardiovascular
    1. By Value
  8. Other Applications
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Pharmaceutical and Biopharmaceutical Companies
    1. By Value
  3. Government and Academic Institutes
    1. By Value
Canada

Europe Market Analysis

Introduction
By Service
1. Introduction
  1. Service By Value
2. Pre-Formulation Service
  1. By Value
3. Formulation Optimization
  1. By Value
By Dosage Form
1. Introduction
  1. Dosage Form By Value
2. Injectable
  1. By Value
3. Oral
  1. By Value
4. Topical
  1. By Value
5. Other Dosage Forms
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Oncology
  1. By Value
3. Genetic Disorders
  1. By Value
4. Neurology
  1. By Value
5. Infectious Diseases
  1. By Value
6. Respiratory
  1. By Value
7. Cardiovascular
  1. By Value
8. Other Applications
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical and Biopharmaceutical Companies
  1. By Value
3. Government and Academic Institutes
  1. By Value
U.K.
1. By Service
  1. Introduction
    1. Service By Value
  2. Pre-Formulation Service
    1. By Value
  3. Formulation Optimization
    1. By Value
2. By Dosage Form
  1. Introduction
    1. Dosage Form By Value
  2. Injectable
    1. By Value
  3. Oral
    1. By Value
  4. Topical
    1. By Value
  5. Other Dosage Forms
    1. By Value
3. By Applications
  1. Introduction
    1. Applications By Value
  2. Oncology
    1. By Value
  3. Genetic Disorders
    1. By Value
  4. Neurology
    1. By Value
  5. Infectious Diseases
    1. By Value
  6. Respiratory
    1. By Value
  7. Cardiovascular
    1. By Value
  8. Other Applications
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Pharmaceutical and Biopharmaceutical Companies
    1. By Value
  3. Government and Academic Institutes
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Service
1. Introduction
  1. Service By Value
2. Pre-Formulation Service
  1. By Value
3. Formulation Optimization
  1. By Value
By Dosage Form
1. Introduction
  1. Dosage Form By Value
2. Injectable
  1. By Value
3. Oral
  1. By Value
4. Topical
  1. By Value
5. Other Dosage Forms
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Oncology
  1. By Value
3. Genetic Disorders
  1. By Value
4. Neurology
  1. By Value
5. Infectious Diseases
  1. By Value
6. Respiratory
  1. By Value
7. Cardiovascular
  1. By Value
8. Other Applications
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical and Biopharmaceutical Companies
  1. By Value
3. Government and Academic Institutes
  1. By Value
China
1. By Service
  1. Introduction
    1. Service By Value
  2. Pre-Formulation Service
    1. By Value
  3. Formulation Optimization
    1. By Value
2. By Dosage Form
  1. Introduction
    1. Dosage Form By Value
  2. Injectable
    1. By Value
  3. Oral
    1. By Value
  4. Topical
    1. By Value
  5. Other Dosage Forms
    1. By Value
3. By Applications
  1. Introduction
    1. Applications By Value
  2. Oncology
    1. By Value
  3. Genetic Disorders
    1. By Value
  4. Neurology
    1. By Value
  5. Infectious Diseases
    1. By Value
  6. Respiratory
    1. By Value
  7. Cardiovascular
    1. By Value
  8. Other Applications
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Pharmaceutical and Biopharmaceutical Companies
    1. By Value
  3. Government and Academic Institutes
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Service
1. Introduction
  1. Service By Value
2. Pre-Formulation Service
  1. By Value
3. Formulation Optimization
  1. By Value
By Dosage Form
1. Introduction
  1. Dosage Form By Value
2. Injectable
  1. By Value
3. Oral
  1. By Value
4. Topical
  1. By Value
5. Other Dosage Forms
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Oncology
  1. By Value
3. Genetic Disorders
  1. By Value
4. Neurology
  1. By Value
5. Infectious Diseases
  1. By Value
6. Respiratory
  1. By Value
7. Cardiovascular
  1. By Value
8. Other Applications
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical and Biopharmaceutical Companies
  1. By Value
3. Government and Academic Institutes
  1. By Value
UAE
1. By Service
  1. Introduction
    1. Service By Value
  2. Pre-Formulation Service
    1. By Value
  3. Formulation Optimization
    1. By Value
2. By Dosage Form
  1. Introduction
    1. Dosage Form By Value
  2. Injectable
    1. By Value
  3. Oral
    1. By Value
  4. Topical
    1. By Value
  5. Other Dosage Forms
    1. By Value
3. By Applications
  1. Introduction
    1. Applications By Value
  2. Oncology
    1. By Value
  3. Genetic Disorders
    1. By Value
  4. Neurology
    1. By Value
  5. Infectious Diseases
    1. By Value
  6. Respiratory
    1. By Value
  7. Cardiovascular
    1. By Value
  8. Other Applications
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Pharmaceutical and Biopharmaceutical Companies
    1. By Value
  3. Government and Academic Institutes
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Service
1. Introduction
  1. Service By Value
2. Pre-Formulation Service
  1. By Value
3. Formulation Optimization
  1. By Value
By Dosage Form
1. Introduction
  1. Dosage Form By Value
2. Injectable
  1. By Value
3. Oral
  1. By Value
4. Topical
  1. By Value
5. Other Dosage Forms
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Oncology
  1. By Value
3. Genetic Disorders
  1. By Value
4. Neurology
  1. By Value
5. Infectious Diseases
  1. By Value
6. Respiratory
  1. By Value
7. Cardiovascular
  1. By Value
8. Other Applications
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical and Biopharmaceutical Companies
  1. By Value
3. Government and Academic Institutes
  1. By Value
Brazil
1. By Service
  1. Introduction
    1. Service By Value
  2. Pre-Formulation Service
    1. By Value
  3. Formulation Optimization
    1. By Value
2. By Dosage Form
  1. Introduction
    1. Dosage Form By Value
  2. Injectable
    1. By Value
  3. Oral
    1. By Value
  4. Topical
    1. By Value
  5. Other Dosage Forms
    1. By Value
3. By Applications
  1. Introduction
    1. Applications By Value
  2. Oncology
    1. By Value
  3. Genetic Disorders
    1. By Value
  4. Neurology
    1. By Value
  5. Infectious Diseases
    1. By Value
  6. Respiratory
    1. By Value
  7. Cardiovascular
    1. By Value
  8. Other Applications
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Pharmaceutical and Biopharmaceutical Companies
    1. By Value
  3. Government and Academic Institutes
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Formulation Development Outsourcing Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Charles River Laboratories International Inc
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Aizant Drug Research Solutions Pvt. Ltd
Catalent Inc.
Laboratory Corporation of America Holdings
Biocon Limited (Syngene International)
IRISYS LLC
Intertek Group PLC
Piramal Enterprises Ltd
Qiotient Sciences
Thermo Fisher Scientific Inc. (Patheon)
Emergent BioSolutions Inc
Lonza Group AG
Aurigene Pharmaceutical Services Ltd
PCI Pharma Services
Hermes Pharma
Pyramid Laboratories Inc

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment